Dirk Abeel

Global Medical Sales Director
Reckitt Benckiser

Dirk drives salesforce effectiveness, CRM systems and capability building within medical sales across the globe, ensuring the company’s successful transition from ‘face-to-face’ to a more omnichannel and digital-based sales approach. He works closely with the medical affairs, marketing and brand teams to provide valuable solutions and customer- and patient journeys. Dirk believes that the pharma industry needs to increasingly leverage insights from data to bring more value to society. Silos need to be broken down both within companies and between companies. He believes the pharma industry will see many more ad hoc alliances between stakeholders in the future, and that the landscape will become a lot more dynamic.

Check out the incredible speaker line-up to see who will be joining Dirk.

Download The Latest Agenda

Day One - 23rd September 2020

Wednesday, September 23rd, 2020

4:45 PM Panel & Interactive Polling: What is the best approach to boosting collaboration across the healthcare market, with pharma companies, HCPs, solution providers and patients to realise new patient-centric solutions that benefit wider society?

Creating solutions that simultaneously benefit patients, customers, society and your business is a key challenge for most pharma companies. Join our pannelists as they share top tips on how collaboration between industry stakeholders can help to turn this vision into a reality.

· How can pharma companies and HCPs explore new ways of working together to raise awareness around key health issues within the wider population?

· How can commercial leaders work in partnership with doctors to ensure the right treatments are reaching the right patients?

· How can increased information sharing help to develop products that satisfy the needs of the future market whilst navigating the evolving pan-EU pharma landscape?

· How can you best collaborate with other pharma companies to collectively overcome legal and regulatory hurdles when developing new solutions for HCPs and patients?

· How strategic alliances can help pharma companies to strengthen their position